Finerenone for chronic kidney disease in type 2 diabetes

Listen to the episode

Description

Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

In this episode:

  • Approved indication and PBS clinical criteria for finerenone
  • Safety profile and benefits of finerenone for type 2 diabetes patients with CKD
  • Initiation, dosing and titration process
  • What this treatment means for GPs and their type 2 diabetes patients with CKD

 

Total time: 7 mins

Last Updated: 9 Apr, 2024

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm

A/Prof Ralph Audehm

Lipids Management in GP Demystified

Dr Anita Munoz

Dr Anita Munoz

Maintaining Muscles of Independence – Sarcopenia Screening & Management

Dr Melissa Bochner

Dr Melissa Bochner

Work Up of a Breast Lump in GP – Practical Tips and Traps

Dr Adam Straub

Dr Adam Straub

Managing Opioid Dependence in GP – An Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sunil Badve

expert

Prof Sunil Badve

Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.